Skip to main content

‘heart disease’

Drug development under way with discovery of how to treat heart attack

Feb. 16, 2021—Vanderbilt researchers have identified the protein receptor in specialized heart cells that, when removed, preserves cardiac function after a heart attack. This discovery has significant implications for survival after a heart attack, with a promising therapeutic development now underway at the Warren Center for Neuroscience Drug Discovery. The research was led by David Merryman, a...

Read more


Merryman wins $6M to address heart disease with arthritis drug, fund other research

Feb. 1, 2017—A Vanderbilt biomedical engineering professor has garnered $6 million total in grants to determine how to treat heart valve disease, pulmonary hypertension and heart failure using drugs originally developed for rheumatoid arthritis and applying the lessons learned from failed weight loss drugs. The larger grant to Associate Professor of Biomedical Engineering David Merryman – the result...

Read more


Heart disease researcher to deliver Emerging Scholars Lecture April 19

Apr. 11, 2016—A researcher who focuses on heart disease and ‘organs on chip’ platforms for disease modeling will deliver the second Emerging Scholars in Engineering Lecture Tuesday, April 19. Renita E. Horton’s lecture — Engineering Approaches to Cardiovascular Diseases: Matters of the Heart – is at 1 p.m. in Stevenson Center 5, room 5326. Lunch will be...

Read more